First Fluorescent Probe for TREX1 Enables Real-Time Tracking of DNA Repair and Immune Regulation in Cancer Cells
Analytical Chemistry · 2025
DOI: 10.1021/acs.analchem.5c00801 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, 2025. Verfasst von Ying Sun und 8 weiteren Autor:innen. Beteiligte Einrichtung: Beijing National Laboratory for Molecular Sciences and MOE Key Laboratory of Bioorganic Chemistry and Molecular Engineering, College of Chemistry and…. Hauptthemen laut MEDLINE: Exodeoxyribonucleases, Phosphoproteins, Fluorescent Dyes, DNA Repair. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Three Prime Repair Exonuclease 1 (TREX1) is the most abundant 3' exonuclease in human cells, playing a pivotal and complex role in both autoimmune regulation and cancer immunity. Despite its importance, existing methods have been insufficient for directly tracking the real-time dynamics of endogenous TREX1 in living cells. To address this gap, we developed a dual-modified DNA fluorescent probe (Probe-TREX1) that enables rapid quantification of TREX1 activity, live-cell imaging across subcellular compartments, and visualization of its distribution in tumor and adjacent nontumor tissues. Our results reveal that TREX1 levels in the nuclei of normal and cancer cells are comparable to or even higher than those in the cytoplasm. Upon stimulation with anticancer drugs, nuclear TREX1 levels, especially in euchromatin regions, rose rapidly, matching or exceeding the increases seen in the cytoplasm, suggesting a significant role for TREX1 in the nucleus. Notably, TREX1 expression was lower in hepatoblastoma and the other two investigated tumor tissues compared to adjacent non-tumor tissues, highlighting the complexity of TREX1's roles in DNA repair and immune response across different tumor types. This study introduces a valuable molecular tool for advancing our understanding of the diverse functions of TREX1, with a broad potential for evaluating and improving cancer therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Beijing National Laboratory for Molecular Sciences and MOE Key Laboratory of Bioorganic Chemistry and Molecular Engineering, College of Chemistry and Molecular Engineering, Peking University, Beijing 100871, China.
- Beijing Jingdu Children's Hospital, Beijing 102208, China.
- Hepatobiliary and Gastrointestinal Department of PLA Rocket Force Characteristic Medical Center, Beijing 100086, China.
ORCID-Profile: Meiping Zhao
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Sun, Y., Zheng, J., Zhang, Y., Zhang, R., Cao, X., Liu, X., Liu, J., Duan, W., & Zhao, M. (2025). First Fluorescent Probe for TREX1 Enables Real-Time Tracking of DNA Repair and Immune Regulation in Cancer Cells. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.5c00801
Vancouver
Sun Y, Zheng J, Zhang Y, Zhang R, Cao X, Liu X, et al. First Fluorescent Probe for TREX1 Enables Real-Time Tracking of DNA Repair and Immune Regulation in Cancer Cells. Analytical Chemistry. 2025. doi:10.1021/acs.analchem.5c00801
BibTeX
@article{Sun2025,
author = {Sun, Ying and Zheng, Jinghui and Zhang, Yupei and Zhang, Ruilan and Cao, Xiangjian and Liu, Xiang and Liu, Jungui and Duan, Weihong and Zhao, Meiping},
title = {First Fluorescent Probe for TREX1 Enables Real-Time Tracking of DNA Repair and Immune Regulation in Cancer Cells},
journal = {Analytical Chemistry},
year = {2025},
doi = {10.1021/acs.analchem.5c00801}
}
EUVIMED